World

Home / World / Americas

Alzheimer's drug shows promise in early results of study

China Daily Global | Updated: 2022-09-29 09:29

Share - WeChat

Japan's pharmaceutical company Eisai and US biotech company Biogen said on Tuesday that their joint Alzheimer's treatment, which appeared to slow the fatal disease in a late-stage study, has been submitted to the US Food and Drug Administration for accelerated approval.

Photos

New US tariffs are an extra burden for developing countries

China protests Japan's detention of fishing boat

Lee Jae-myung leads poll for S. Korean presidential election

China urges US not to politicize educational cooperation

Suspect in fatal shooting of 2 Israeli embassy staff charged with murder

US federal judge blocks Trump's bid to dismantle Department of Education

Most Viewed in 24 Hours

World in Focus

Journey to recovery

Across Asia +

Japanese consumers turn to rice alternatives in price surge

Preparedness a priority

Special Coverage +

7.9-magnitude earthquake hits Myanmar

Russia-Ukraine conflict: Three years on

Friends Afar +

Ballet maestro's fond China memories

Ties That Bind +

Vital pass to boost China-Pakistan trade

BACK TO THE TOP

English

中文

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.

Registration Number: 130349